5 cannabis strains for people who love oranges
Marijuana Stocks, Finance, & InvestingUncategorized May 30, 2020
What’s the best fruit? If you answered oranges, then your day just got even better because there are plenty of weed strains that smell and taste just like them.
Read moreNuminus Announces 2020 Operational Plans to Scale
Marijuana Stocks, Finance, & InvestingUncategorized May 29, 2020
Newly-listed Numinus Wellness provides a corporate update.
Read moreCalifornia Nets $134.9M From 1st-Quarter Cannabis Taxes
Marijuana Stocks, Finance, & InvestingUncategorized May 29, 2020
California cannabis taxes generated nearly $135 million during the first quarter of 2020, which is $42.4 million less than the state’s 2019 first-quarter cannabis tax revenue.
Read more7 Marijuana Stocks to Watch as the Presidential Election Approaches
Marijuana Stocks, Finance, & InvestingUncategorized May 29, 2020
In the months leading up to the presidential election, markets may renew their bullishness in companies that sell marijuana.
Read moreSmall Dispensary Wins Trademark Dispute Against Multi-State Operator
Marijuana Stocks, Finance, & InvestingUncategorized May 29, 2020
Arkansas-based Harvest Cannabis Dispensary has won a preliminary injunction in its trademark dispute against Natural State Enterprises, a multi-state cannabis operator.
Read moreChampignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing
Marijuana Stocks, Finance, & InvestingUncategorized May 29, 2020
Certain shareholders have agreed to a voluntary resale restriction that covers 17.8 million shares.
Read morePsychedelic Drug Therapy: Laying Out The Picture
Marijuana Stocks, Finance, & InvestingUncategorized May 28, 2020
Psychedelic drug proponents have touted some very exciting clinical studies. Investors will want to look past the headlines and take a closer look at these drug therapies.
Read moreMindMed Adds MDMA for Development of Next-Gen Psychedelic Therapies
Marijuana Stocks, Finance, & InvestingUncategorized May 28, 2020
MindMed further expands R&D collaboration with University Hospital Basel’s Liechti Lab with plans to develop next-gen psychedelic therapies combining LSD and MDMA.
Read moreMindMed Closes on Upsized Financing of $13.2m
Marijuana Stocks, Finance, & InvestingUncategorized May 26, 2020
MindMed has issued 24.95 million units at a unit price of CAD$0.53.
Read moreDr. Gabor Maté joins Numinus as Member of the Clinical Advisory Council
Marijuana Stocks, Finance, & InvestingUncategorized May 26, 2020
Maté will collaborate with the Numinus team in an advisory capacity and facilitate connections within the mental health community.
Read more